Unity Biotechnology, Inc.

NASDAQ:UBX

1.44 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Assets:
Current Assets:
Cash & Cash Equivalents 19.80312.73632.90517.80737.47315.3997.29889.286
Short Term Investments 23.39882.05955.1779.89290.015155.73679.2120
Cash and Short Term Investments 43.20194.79588.07597.699127.488171.13586.5189.286
Net Receivables 1.5770.23500001.3820
Inventory 0-0.235000000
Other Current Assets 1.8271.741.8793.1671.9991.830.9884.123
Total Current Assets 46.60596.53590.504100.866129.487172.96588.8893.409
Non-Current Assets:
Property, Plant & Equipment, Net 18.06326.86731.22836.13616.6366.2386.9582.248
Goodwill 00000000
Intangible Assets 00000000
Goodwill and Intangible Assets 00000000
Long Term Investments 0.8960.8961.99317.8713.0251.1515.1180.652
Tax Assets 00000000
Other Non-Current Assets 0.1260.0520.9871.4462.0731.0211.0680.339
Total Non-Current Assets 19.08527.81534.20855.45321.7348.4113.1443.239
Total Assets 65.69124.35124.712156.319151.221181.375102.02496.648
Liabilities & Equity:
Current Liabilities:
Account Payables 1.381.791.9852.5585.1854.8472.3780.964
Short Term Debt 3.4519.4763.0554.520.0450.0780.0780
Tax Payables 00000000
Deferred Revenue 000.2167.364-0.045-0.078-0.0780
Other Current Liabilities 3.0098.35411.3610.02112.03111.7355.5192.727
Total Current Liabilities 7.8419.6216.61714.46317.21616.5827.8973.691
Non-Current Liabilities:
Long Term Debt 23.53937.88248.50358.97600.04500
Deferred Revenue Non-Current 00000000
Deferred Tax Liabilities Non-Current 00000000
Other Non-Current Liabilities 5.91300.023013.2984.0553.284134.493
Total Non-Current Liabilities 29.45237.88248.52658.97613.2984.13.284134.493
Total Liabilities 37.29257.50265.14373.43930.51420.68211.181138.184
Equity:
Preferred Stock 00000181.375173.956131.089
Common Stock 0.0020.0010.0060.0050.0050.0040.0030.001
Retained Earnings -484.353-459.951-400.024-339.299-245.455-163.278-86.88-42.224
Accumulated Other Comprehensive Income/Loss -0.024-0.251-0.0440.0050.09-0.095-0.104-0.202
Other Total Stockholders Equity 512.773527.049459.631422.169366.067142.6873.868-130.2
Total Shareholders Equity 28.39866.84859.56982.88120.707160.69390.843-41.536
Total Equity 28.39866.84859.56982.88120.707160.69390.843-41.536
Total Liabilities & Shareholders Equity 65.69124.35124.712156.319151.221181.375102.02496.648